Genotype analysis identifies the cause of the "royal disease"
- PMID: 19815722
- DOI: 10.1126/science.1180660
Genotype analysis identifies the cause of the "royal disease"
Abstract
The "royal disease," a blood disorder transmitted from Queen Victoria to European royal families, is a striking example of X-linked recessive inheritance. Although the disease is widely recognized to be a form of the blood clotting disorder hemophilia, its molecular basis has never been identified, and the royal disease is now likely extinct. We identified the likely disease-causing mutation by applying genomic methodologies (multiplex target amplification and massively parallel sequencing) to historical specimens from the Romanov branch of the royal family. The mutation occurs in F9, a gene on the X chromosome that encodes blood coagulation factor IX, and is predicted to alter RNA splicing and to lead to production of a truncated form of factor IX. Thus, the royal disease is the severe form of hemophilia, also known as hemophilia B or Christmas disease.
Similar articles
-
[Genomics of the royal disease, Queen Victoria's hemophilia].Med Sci (Paris). 2010 Feb;26(2):201-3. doi: 10.1051/medsci/2010262201. Med Sci (Paris). 2010. PMID: 20188053 French. No abstract available.
-
Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.Haematologica. 2004 Dec;89(12):1498-503. Haematologica. 2004. PMID: 15590401
-
Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNA.J Thromb Haemost. 2017 Nov;15(11):2188-2197. doi: 10.1111/jth.13808. Epub 2017 Sep 25. J Thromb Haemost. 2017. PMID: 28834196
-
The 'royal disease'--haemophilia A or B? A haematological mystery is finally solved.Haemophilia. 2010 Nov;16(6):843-7. doi: 10.1111/j.1365-2516.2010.02327.x. Haemophilia. 2010. PMID: 20557352 Review.
-
The Molecular Basis of FIX Deficiency in Hemophilia B.Int J Mol Sci. 2022 Mar 2;23(5):2762. doi: 10.3390/ijms23052762. Int J Mol Sci. 2022. PMID: 35269902 Free PMC article. Review.
Cited by
-
Thrombotic Disease in Hemophilic Patients: Is This a Paradox in a State of Hypocoagulability?Diagnostics (Basel). 2024 Jan 29;14(3):286. doi: 10.3390/diagnostics14030286. Diagnostics (Basel). 2024. PMID: 38337802 Free PMC article. Review.
-
Albumin-Fusion Recombinant FIX in the Management of People with Hemophilia B: An Evidence-Based Review.Drug Des Devel Ther. 2022 Sep 15;16:3109-3116. doi: 10.2147/DDDT.S236788. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36132333 Free PMC article. Review.
-
The Clinical Genetics of Hemophilia B (Factor IX Deficiency).Appl Clin Genet. 2021 Nov 23;14:445-454. doi: 10.2147/TACG.S288256. eCollection 2021. Appl Clin Genet. 2021. PMID: 34848993 Free PMC article. Review.
-
Haemophilia.Nat Rev Dis Primers. 2021 Jun 24;7(1):45. doi: 10.1038/s41572-021-00278-x. Nat Rev Dis Primers. 2021. PMID: 34168126 Review.
-
Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).Calcif Tissue Int. 2021 Nov;109(5):577-585. doi: 10.1007/s00223-021-00872-x. Epub 2021 Jun 12. Calcif Tissue Int. 2021. PMID: 34117910 Free PMC article.
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous